IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

CPhI: Saltigo Develops Generic Pharmaceuticals Strategy

4:29 AM MDT | October 14, 2009 | Deepti Ramesh in Madrid

Saltigo, the custom synthesis and manufacturing services subsidiary of Lanxess, says the business is trying to develop strategies for manufacturing generic drugs for its pharma customers. Additionally, the business says that in future there will be more alliances between pharmaceutical contract manufacturers. “Custom manufacturing companies with different expertise such as those with expertise in technology and with lower cost platforms will form more alliances in the future,” Andreas Stolle, head of the pharma business line pharma at Saltigo, tells...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa